Navigation Links
InspireMD Announces Upcoming Investor Event in Israel

BOSTON, November 19, 2013 /PRNewswire/ --

InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection stents, today announced that it will host an investor event at the Dan Tel Aviv Hotel in Tel Aviv, Israel on December 2, 2013 at 5:00 p.m. local time.

At the event, the senior management team of InspireMD will review the recently announced 12-month follow up data from its MASTER trial, discuss its recent clinical and operational efforts, and answer questions from the audience.  

Investors wishing to attend the event should RSVP to with "Investor Event" in the subject line.

About Stenting and MGuard™ EPS

Standard stents were not engineered for heart attack patients. They were designed for treating stable angina patients whose occlusion is different from that of an occlusion in a heart attack patient.

In acute heart attack patients, the plaque or thrombus is unstable and often breaks up as the stent is implanted causing downstream blockages (some of which can be fatal) in a significant portion of heart attack patients.

The MGuard EPS is integrated with a precisely engineered micro net mesh that prevents the unstable arterial plaque and thrombus (clots) that caused the heart attack blockage from breaking off.

While offering superior performance relative to standard stents in STEMI patients with regard to ST segment resolution, the MGuard EPS requires no change in current physician practice - an important factor in promoting acceptance and general use in time-critical emergency settings.

About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MGuard™ technology to make its products the industry standard for embolic protection stents and to provide a superior solution to the key clinical is

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. InspireMD Files At-the-Market Offering and Shelf Registration Statement
2. InspireMD Secures Financing to Accelerate Advancements in Product Development and Adopts a One Year Stockholder Rights Plan
3. InspireMD To Participate In Benchmark Investor Conference On May 30th
4. InspireMD Hires Vice President of Corporate Development
5. Michael Berman Joins InspireMD Board
6. InspireMD Postpones $40 Million Registered
7. InspireMD Reports 2012 Fiscal Year Results
8. InspireMD to Present at JMP Securities Healthcare Conference on July 12th in New York
9. InspireMD to Present at JMP Securities Healthcare Conferenceon July 12th in New York
10. InspireMD Appoints Dr. James Barry to Its Board of Directors
11. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
Post Your Comments:
(Date:7/29/2014)... 29, 2014  Discovery Laboratories, Inc. (Nasdaq: DSCO),  ... new standard of respiratory critical care, will report its ... 2014 before the open of the U.S. financial ... a live teleconference and webcast at 9:00 a.m. Eastern ... Discovery Labs, management will discuss the 2014 second ...
(Date:7/29/2014)... A new report by Allied ... and geography) - Size, Share, Global Trends, Company Profiles, ... 2013 - 2020", suggests that the global surgical equipment ... registering a CAGR of 11.1% from 2014 to 2020. ... electro surgical devices in operative procedures by providing highly ...
(Date:7/29/2014)... BEVERLY HILLS, Calif. , July 29, 2014 ... company specializing in personalized medicine, treatment of infectious ... developing strategies of prognosis and prevention of pathologies ...  As of August 1, 2014, ImmunoClin Corporation will ... to Washington, D.C. , a ...
(Date:7/29/2014)... & Rockville, MD (PRWEB) July 29, 2014 ... Inc. (ITI), a vaccine pioneer in the biotechnology ... services firm Newport Coast Securities, Inc. to explore ... is commercializing LAMP-vax technology, a breakthrough vaccine platform ... and immunotherapy market. The company exclusively licensed the ...
Breaking Biology Technology:Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 3ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 2ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 3Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3
... Arbios Systems, Inc.,(OTC Bulletin Board: ABOS) today announced ... in its bioartificial liver system, HepatAssist, to HepaLife,Technologies, ... developing proprietary cell-based medical technologies to improve,protect and ... The terms of the deal included $450,000 in ...
... Patients Describe Their Life-Changing Results, CHAPEL HILL, ... classic "talk therapy" with a dynamic new set ... -- especially with,chronic health conditions such as pain, ... including Post Traumatic Stress Disorder (PTSD).,Known as "Energy ...
... Oct. 7, 2008 Senomyx, Inc.,(Nasdaq: SNMX ... taste,receptor technologies to discover and develop novel flavor ... announced today that,Kent Snyder, the Company,s President and ... and Business Officer, will present a,corporate overview on ...
Cached Biology Technology:Arbios Sells HepatAssist Bioartificial Liver System to HepaLife Technologies, Inc. 2Arbios Sells HepatAssist Bioartificial Liver System to HepaLife Technologies, Inc. 3Upcoming 'Energy Psychology' Event - New Breakthrough 'Do It Yourself' Healing 2SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE 2
(Date:7/29/2014)... is the first to show that while the impact ... these negative effects may be reduced by maintaining a ... study participants who exercised, slept well and ate well ... maintain healthy lifestyles, even when they had similar levels ... professor in the department of psychiatry at UCSF. "It,s ...
(Date:7/28/2014)... Millions of people in the United States have a ... It can be painful and may even require surgery ... skeletal muscle wasting and, in turn, limb amputation. , ... Houston (UTHealth) Medical School, scientists tested a non-surgical preventative ... it was associated with increased blood circulation. Their ...
(Date:7/28/2014)... pennellii , a wild relative of the domestic tomato, ... including the labs headed by Professors Neelima Sinha and ... Biology. The new genome information may help breeders produce ... 27 in the journal Nature Genetics , was ... in Germany. The UC Davis labs carried out work ...
Breaking Biology News(10 mins):Healthy lifestyle may buffer against stress-related cell aging, study says 2Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2
... published online in the open-access journal PLoS Pathogens, Dr. ... colleagues identify new host species for avian influenza A ... between the ecology and epidemiology of various global strains ... included more than 36,000 wild migratory birds tested for ...
... of Missouri-Columbia has discovered a way to create engineered ... This discovery opens new possibilities for the development of ... bacteria and herbicides, and for the development of proteins ... illnesses. , In a paper published in the Proceedings ...
... genetic adaptations in the nematode Acrobeloides nanus. The ... more eggs under polluted conditions than the worms ... this in her study into the long-term effects ... Environmental pollution is an important cause of stress ...
Cached Biology News:Researchers attach genes to minichromosomes in maize 2Asexual worm quickly adapts to soil contamination 2
XBP-1 (F-4)...
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
pETDuet-1 is designed for the coexpression of two target genes....
Biology Products: